Screener
Bruker BRKR Bsi Biospin — D&A
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bruker in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The source filing: Bruker’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:24 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335226
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Corporate | 3.5 | 6.9 | 5.8 | 11.6 |
| Total capital expenditures | $20.3 | $30.3 | $38.2 | $56.3 |
| Depreciation and Amortization: | ||||
| BSI BioSpin | $9.4 | $11.2 | $21.1 | $21.6 |
| BSI CALID | 27.4 | 23.4 | 52.0 | 43.2 |
| BSI NANO | 15.9 | 17.1 | 32.9 | 33.8 |
| BEST | 2.6 | 2.4 | 5.2 | 4.5 |
| Corporate | 2.7 | 2.0 | 5.1 | 3.4 |
ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Bruker's bsi biospin — D&A?
- Bruker (BRKR) reported bsi biospin — D&A of $9.4M in Q2 2026.
- How has Bruker's bsi biospin — D&A changed year-over-year?
- Bruker's bsi biospin — D&A decreased by 16.1% year-over-year, from $11.2M to $9.4M.
- What is the long-term trend for Bruker's bsi biospin — D&A?
- Over 4 years (2021 to 2025), Bruker's bsi biospin — D&A has grown at a 19.3% compound annual growth rate (CAGR), from $21.3M to $43.2M.
- What does bsi biospin — D&A mean?
- This is the non-cash expense allocated to the BioSpin segment to account for the wear and tear or expiration of its long-lived assets over time. It reflects the systematic reduction in the value of equipment and intangible assets used in the segment's operations. It is a key component in reconciling net income to cash flow.
Ask your AI about Bruker's bsi biospin — d&a.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude